Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-02-02 @ 2:43 AM
Study NCT ID:
NCT05599334
Status:
COMPLETED
Last Update Posted:
2025-10-06
First Post:
2022-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib
Sponsor:
Pierre Fabre Medicament
Organization: